Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
Clinicaltrials.gov Identifier:All clinical trials available on ClinicalTrials.gov are given an official number by the United States government. This helps people easily search for and find a certain trial.
Trial details
How far along a trial is in the process. There are several phases: Phase 1, Phase 2, Phase 3 and Phase 4.
Trials that are looking for healthy people to participate.
The disease(s) being studied in a trial.
Asthma
An interventional trial typically studies a potential medicine. An observational trial watches a person's health over time with no investigational medicine given.
Interventional
The new medicine being studied.
dupilumab, ICS/LABA, Matching Placebo
The number of people the researchers want in the trial.
250
Trial summary
This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condition where the airways narrow and swell, making it difficult to breathe. Uncontrolled asthma means that patients are still having frequent symptoms while taking their current asthma medication.
The aim of the study is to see which regimen is more effective: taking dupilumab with an inhaled asthma medication or only taking a higher dose of the inhaled asthma medication. The type of asthma medication that will be used is a combination inhaled corticosteroid and long-acting beta-agonist (referred to as an ICS/LABA). Some patients may also receive an additional asthma medication called a long-acting muscarinic antagonist (referred to as a LAMA) if they are already receiving a LAMA.
The study is also looking at:
• What side effects may happen from taking dupilumab
Trial locations
0 location(s)